Properties of Paramagnetic Metals in MRI by Schaefer, Michel
PROPERTIES OF PARAMAGNETIC METALS IN MRI
Michel Schaefer
Laboratoire GUERBET, 18-24, rue Jean Chaptal,
Aulnay-sous-Bois B.P. 50400, F-95943 Roissy CdG Cedex, France
ABSTRACT
h’ ue of different metals in Magnetic Resonance Imaging will be briefly described.
This overview will be more a qualitative description than a full paper on this topic, in other words, this
paper contributes to explaining how and why some metal ions have been chosen for MRI.
Paramagnetic compounds are currently used in clinical practice. The main differencesin the four gadolinium
complexes come from their different chemical structures. The macrocyclic compounds display a high
symmetry and rigidity and therefore a high level of stability.
All these four complexes display the same efficacyon the signal in MRI. In addition, they are very well
tolerated.
The second main class of compounds consists ofthe iron oxide superparamagnetic particles. They are used in
the detection of focal liver lesions. Through their action in dephasing the spin, they are used as negative
enhancers.
I. INTRODUCTION
Be’foreentering into the details of Magnetic Resonance Imaging, it is worth comparing two of the most
important tools used in medical diagnostics X-rays and MR imaging.
These two modalities can be compared in terms of differences and complementarities (fig 1).
X-Ray imaging needs high energy and radiations. Essentially hard tissues like bones can be visualised. In
fact, the heavy metals like calcium interact with X-Rays and give off a signal. This signal is obtained through
the interaction between the X-Ray beam and the electronic shell of atoms with high atomic numbers.
Thus, the best contrast media for X-Ray imaging will be molecules or atoms with high atomic numbers and
a k-Edge in the range of X-Ray energy used in scanner machines. Direct interaction is obtained between
iodinated molecules which are used as contrast media in this technique and X-Rays. This explains why the
technique requires large amount of contrast media. In other words, the contrast media are directly < seen >> on
the image.
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Fig. 1: Differences and complementarity ofX-ray and MR
imaging techniques. From An Introduction To MR in
Medicine (Ref. 1).
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Conversely, magnetic resonance imaging does not require high energy. The patient is introduced into a
magnetic field. In MRI, it is the soft tissues which are visualised best. The images are obtained with the
signal coming from the lipid and water protons. The image contrast is obtained through the relaxation times
T1 and T2 of the different tissues. Injection of contrast media will modify both relaxation times T1 and T2
and then induce contrast enhancement. There is an indirect interaction between the contrast media and the
signal. This explains the relatively low amount of substance injected in comparison with X-Ray modalities.
Unlike the results obtained with X-rays, the contrast material is not directly visualised in MRI.
II -CONTRAST IN MAGNETIC RESONANCE IMAGING
The contrast between the tissues in MRI mainly comes from three parameters" the amount of protons, so
called proton density, and their two relaxations times T1 and T2.
Fig 2 the three main parameters on which we can act to
modify the contrast.
As it is difficult and dangerous to modify the amount ofwater or fat in vivo, the substances used to increase
the contrast will act in modifying the relaxation times (fig.2). It can be demonstrated that the dipolar
interaction between free or unpaired electrons and water molecules induces a dramatic decrease in T and T2.
Ill. PARAMAGNETIC COMPOUNDS
Table 1" among the metals possessing unpaired electrons,
Gadolinium, Manganese and Iron appear the most powerful
with 7, 5 and 5 unpaired electrons, respectively.
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The best carriers of free -or unpaired- electrons, beside the free radicals are metals. Table shows that the best
metal ions are manganese and particularly gadolinium. Iron and gadolinium-based compounds are currently
used in clinical practice. Manganese compounds are under clinical trial (Fig.3 summarizes the paramagnetic
action).
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Fig 3: Paramagnetic compounds are mainly used as positive
enhancers in Tl-weighted sequences.
a- Mechanism"
The dipolar interaction between water molecule protons and unpaired electrons is described by the Solomon-
Bloembergen equation (fig. 5).
Fig 4: The dipolar interaction between water molecules and
metal ion is responsible for the paramagnetic efficacy. Two
simultaneous phenomena contribute to the relaxivity: the
water moleculesfrom the inner sphere (directly bound to the
metal) and free water molecules coming from the
surrounding tissues.
In these equations, two parameters are very important: r which is the distance between the metal and the
proton of the water molecule. This distance must be as short as possible in order to increase the efficacy.If r
increases slightly, r increases dramatically and the efficacy almost vanishes (fig. 4).
The second important parameter is xc which represents the movements of the paramagnetic molecule. This
correlation time is composed ofthree parameters"
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xs which is the electronic correlation time related to the symmetry and rigidity of the gadolinium
complexes. From this point of view, the macrocyclic complexes are advantageous as they display a higher
symmetry than the linear complexes and therefore have a longer electronic correlation time. This is very
important when synthesizing new compounds with increased relaxivity. As the correlation time must be as
high as possible, it is understandable that this electronic correlation time should not be a limiting factor (fig.
6).
"R the rotation correlation time can be increased synthesizing bigger molecules. In this way, the rotation
rate of such big molecules will be slower and thus their rotation correlation time longer. This is a very
important point in the search for new and more powerful products.
Fig 5: Solomon/Bloembergen equation. The paramagnetic
efficacy, the relaxivity, depends chiefly on three parameters
the number of water molecules around the metal, the
distance r between them and the correlation time zc.
Fig 6: At low field strengh, the higher relaxivity displayed
by the macrocycle is due to its longer electronic correlation
time zs because of the higher symmetry and rigidity of the
macrocyclic structure.
’M the exchange correlation time is the most difficult to manage as it appears in two equations (fig. 7). This
correlation time represents the residence time for a water molecule fixed to the metal ion. It must represent the
best compromise between a long period of time in order for a water molecule to be relaxed, and a short
residence time to ensure the fast turn over of other molecules. In other words, XM should not be a limiting
factor. The precise analysis of all these correlation times is perfectly described in Merbach’s paper (ref. 2).
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Fig 7: The exchange correlation time appears in the two
equations and need to be well managed. In other words, the
best compromise must befound concerning its value.
The gadolinium metal ion with nine water molecules in its first hydration sphere is very efficient with a
relaxivity of 9 mM-1. s-l, but it is toxic in vivo (fig. 8). In fact, the gadolinium with an ionic radius similar
to the calcium ion, can interfere with numerous metal-dependent enzymatic systems. Therefore, it must be
complexed in order to mask its toxicity, but this results in decreased relaxivity (table 2).
b- Tolerance"
DOTA :
!:,:.:,,i.:,’:;:::: :,:. DOTAREM ...... .::.::.(R)5... .:.. ..lL/i.:.!
Fig 8: Gadolinium metal ion is toxic through its possible
interference with metal dependent systems. The plain chelate
is also toxic as it can complex any endogenous metal The
gadolinium decomplexation by the appropriate chelate
allows a gain in tolerance by afactor more titan 100.
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Table 2: Whatever the metal, complexation leads to a
decrease in relaxivity. By surrounding the metals by a
chelate, the water molecules are removed. Free gadolinium
ion possesses 9 water molecules andjust 1 when complexed.
Four gadolinium complexes are currently available on the market. Most of their properties come from their
different chemical structures (fig. 9). They can be divided in four main categories according to their structures:
macrocyclic or linear, and according to their nature: ionic or non-ionic.
Fig 9: Four gadolinium complexes are available on the
International market. They differ by their chemical
structures. Two main classes" linear and macrocyclic
structures.
Thanks to the low amount of compounds injected in MRI, the ionicity of the complexes is not a crucial
factor as the increase of plasma osmolality is very low, unlike what is observed in X-Ray imaging. The
stability of the complexes must be as high as possible to avoid any in-vivo decomplexation.
Macrocyclic complexes display the highest thermodynamic stability constant (fig. 10).
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Fig. 10: Thermodynamic constants show that macrocyclic
structures are the most stable.
Moreover, at physiological pH, the ionic complexes are the most stable (fig. 1).
Kinetic stability is also a very important factor as it conditions possible in-vivo transmetallations (table 3).
In vitro, measurements confirm this behaviour when the four gadolinium complexes currently available on the
market are placed in competitive conditions with zinc salt for example.
Fig. 11: Conditional stability constants at physiological pH
show that ionic structures are the most stable.
Practically no exchange takes place with macrocycles (fig. 12).
In the same way, in-vivo gadolinium retention has been monitored in mice. After 14 days, the gadolinium in
bones was below the limit of detection ofthe methods for the two macrocyclic complexes.
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Table 3: This table displays the half-life of complexes placed
in very acidic conditions in order to accelerate the
decomplexation phenomenon and to allow its measurement.
Fig 12: This diagram shows the percentage of the exchange
with zinc salt after_ hour in-vitro (ref. 3).
The injected doses were 4 times the human clinical doses and the amounts found in bones were very low (fig.
13). We can thus conclude that all these 4 gadolinium complexes used as contrast media in MRI are very safe
and well tolerated. The usual dose injected in humans is 0.1 mmol/Kg. These compounds are called non-
specific as they are very hydrophilic, they do not bind to proteins or receptors, they are excreted
unmetabolized in urine and are considered as extra-cellular fluid markers.
Some others metal complexes are under clinical trial as specific compounds. For example, lipophilic
gadolinium complexes and Manganese complexes are studied as hepatocyte-targeted compounds for liver
imaging (table 4).
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Fig 13: percentage ofGd retention in bone in mice after 14
days (ref. 4).
IV. SUPER PARAMAGNETIC PARTICLES
Iron Oxide particles represent the second.most important class of metal derivatives used for MR imaging.
These superparamagnetic particles are synthesized through a co-precipitation of FeII and FeIII in presence of
dextran. Dextran is a polysaccharide used as a coating in order to stabilise the colloidal suspension (fig 14).
Table 4: Besides tle four gadolinium complexes used as
non-specific agents, other more specific compounds are
under development. Among the liver-specific contrast agents,
one superparamagnetic particle is on the market
(ENDOREM ).
These iron oxide particles are called superparamagnetic as they have a high susceptibility as Ferro-magnetic
compounds but they demagnetise very rapidly as paramagnetic molecules when the magnetic field is removed
(fig. 15).
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Fig 14: Manufacturing process of superparamagnetic
particles. After coprecipitation, the suspension is filtered
and stabilized.
. :earspindephasi g: :::
Fig 15: The superparamagnetic particles act mainly in
dephasing the spins. They are generally used as negative
enhancers.
The precise characterization of such particles is very important because their physico-chemical and
pharmacokinetic properties will dramatically depend on their characteristics. Determination of the size of the
iron oxide crystal itself is measured by sophisticated methods. This is important because their size will
determine their magnetic properties (fig. 16).
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Fig 16: The whole particles are made of small iron oxide
crystals coated with dextran. Mannitol and citrate ensure an
iso osmolality to the plasma and contribute to stability.
:PRODUCTS CRYSTAL DIAMETEROF :
Table 5: Sizes ofthe particles.
The size of the iron oxide crystals is very similar whatever
the compound. On the other hand, tle size of the particle
itself is absolutely determining as it will affect all the
properties ofthe compound.
The size of the particle is crucial (table 5). Particle size measurement is performedby laser light scattering.
The largest particles are found in Lumirem which is an oral compound used to darken the bowels in order to
better visualise the adjacent structures in abdominal and pelvic imaging (fig. 17).
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Fig 17: Lumirem is taken orally and helps to improve
definition of the adjacent structures in the pelvis and
abdomen.
Its relaxivities in T1 and T2 show that thiscompound is nearly exclusively a T2 negative enhancer (table 6).
With a diameter of 150 nm, Endorem is a specific compound for liver imaging. The Ktippfer cells present in
normal parenchyma will take up the particles and then induce a T2 effect which will darken the normal liver.
The malignant lesions which lack macrophages will not take up the particles and will appear in iso-signal.
With a smaller diameter of around thirty nm, Sinerem will stay in the blood vessels for a longer period of
time and can be used as a blood-pool agent. At delayed imaging, 24 h after injection, the lymph nodes can be
visualised.
Table 6: The relaxivity depends on the size of the particles.
The T2/T1 effects ratio increases with the size. The larger
the particles, the higher the T2 effect and the darker the
image.
Table 6 shows that relaxivities R1 and R2 and in particular R2/R1 depend mainly on their size. This table
shows that these particles can be used as T1 and T2 agents. The enhancement in T1 will be obtained when
the particles are diluted in the blood vessels for example, giving a so-called angio-effect. The negative
enhancement in T2 is obtained when the particles are concentrated in the macrophages for example, inducing
an important susceptibility effect.
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V. CONCLUSION
in order to use all the compounds under optimal conditions, their precise mechanism should be understood
perfectly. With a constantly improving technique, a global approach must be considered, including MRI
machines, sequences and products. In other words, with special sequences, such as fast imaging techniques,
some compounds can be used as positive or negative enhancers.
Knowledge ofthe structures/efficacy relationships is absolutely necessary to synthetize the future compounds.
For example, the management of the Solomon-Bloembergen equations is very important in order to improve
theefficacy of Gadolinium complexes. More efficientproducts will probably make it possible to reduce the
doses and consequently increase the tolerance.
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